Dennis Kim, MD
Zafgen, Inc.
3
0
1
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
David Meeker, MD
Rhythm Pharmaceuticals, Inc.
Shared therapeutic areas:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
David Crowley, MD
KGK Science Inc.
Shared therapeutic areas:
Lisa Porter, MD
Amylin Pharmaceuticals, LLC.
Shared therapeutic areas:
ali ismail, lecturer
Cairo University
Shared therapeutic areas:
Samuel Klein, MD
Washington University School of Medicine
Shared therapeutic areas:
Adrian Vella, MD
Mayo Clinic
Shared therapeutic areas:
Martine Duclos
University Hospital, Clermont-Ferrand
Shared therapeutic areas:
Shirley Wang, PhD, ScM
Brigham and Women's Hospital
Shared therapeutic areas:
Paolo Bonato, PhD
Spaulding Rehabilitation Hospital
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
Study to Assess the Effects and Safety of ZGN-1061 in Overweight and Obese Participants With Type 2 Diabetes
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
An Efficacy and Safety Study of Beloranib in Obese Subjects With Type 2 Diabetes Mellitus
All 3 trials loaded